Lu Qiu

1.3k total citations
51 papers, 876 citations indexed

About

Lu Qiu is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Lu Qiu has authored 51 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Cell Biology. Recurrent topics in Lu Qiu's work include Genomics, phytochemicals, and oxidative stress (19 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lu Qiu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (19 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lu Qiu collaborates with scholars based in China, United Kingdom and Finland. Lu Qiu's co-authors include Yiguo Zhang, Yuancai Xiang, Yanfeng Gao, Yonggang Ren, Shaofan Hu, Xufang Ru, Yahong Wu, Yuanming Qi, Xiuman Zhou and Shanshan Gou and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Lu Qiu

48 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Qiu China 18 537 180 121 121 102 51 876
Yanliang Lin China 21 532 1.0× 156 0.9× 113 0.9× 229 1.9× 62 0.6× 48 1.1k
Huifang Hu China 13 323 0.6× 125 0.7× 88 0.7× 91 0.8× 80 0.8× 30 606
Xiaofang Lu China 17 375 0.7× 85 0.5× 100 0.8× 133 1.1× 37 0.4× 66 945
Hai-Xia Qi China 8 396 0.7× 114 0.6× 53 0.4× 286 2.4× 92 0.9× 10 777
Xiuying Pei China 20 453 0.8× 145 0.8× 50 0.4× 158 1.3× 81 0.8× 61 1.0k
Г. Е. Онищенко Russia 13 292 0.5× 90 0.5× 77 0.6× 64 0.5× 102 1.0× 52 658
Jiřina Procházková Czechia 16 482 0.9× 57 0.3× 83 0.7× 150 1.2× 109 1.1× 46 827
Xinyuan Liu China 15 559 1.0× 80 0.4× 48 0.4× 248 2.0× 71 0.7× 60 871

Countries citing papers authored by Lu Qiu

Since Specialization
Citations

This map shows the geographic impact of Lu Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Qiu more than expected).

Fields of papers citing papers by Lu Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Qiu. The network helps show where Lu Qiu may publish in the future.

Co-authorship network of co-authors of Lu Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Qiu. A scholar is included among the top collaborators of Lu Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Qiu. Lu Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Lu, et al.. (2025). The impact of write-down equity on bank stability under ambiguity aversion. International Review of Economics & Finance. 98. 103851–103851.
2.
Hussain, Zubair, Yueteng Zhang, Lu Qiu, Shanshan Gou, & Kangdong Liu. (2025). Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials. npj Vaccines. 10(1). 27–27. 8 indexed citations
3.
Ren, Yonggang, et al.. (2024). Systematic regulation of immune checkpoint molecules by redox regulators CNC-bZIP transcription factors. Discover Oncology. 15(1). 685–685. 2 indexed citations
4.
Zhang, Yangyang, et al.. (2024). Biomimetically engineered plant-derived exosomes-like nanovesicles for rheumatoid arthritis therapy. Chinese Chemical Letters. 36(9). 110658–110658. 1 indexed citations
5.
Gao, Taotao, Qi An, Yang Zhang, et al.. (2024). Surface in situ modulation of carbon nanotube-supported Fe–Ni compounds via electrochemical reduction to enhance the catalytic performance for the oxygen evolution reaction. Inorganic Chemistry Frontiers. 11(16). 5054–5063. 9 indexed citations
6.
7.
Zhou, Xiaowen, Li Yang, Beibei Li, et al.. (2024). Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy. Science China Life Sciences. 67(5). 996–1009. 20 indexed citations
8.
An, Lei, Lu Qiu, Ke Wang, & Yousheng Wang. (2023). Urolithins: A Prospective Alternative against Brain Aging. Nutrients. 15(18). 3884–3884. 8 indexed citations
9.
Qiu, Lu, Wenshan Zhao, Yadi Xing, et al.. (2022). Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming. Cell Death and Disease. 13(5). 501–501. 25 indexed citations
10.
Zhou, Xiuman, Yixuan Sun, Wei Zheng, et al.. (2021). Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy. Biomolecules. 11(5). 706–706. 30 indexed citations
11.
Yao, Yongjie, Xiaoxi Wang, Jiaxin Sun, et al.. (2021). Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes. International Immunopharmacology. 100. 108152–108152. 4 indexed citations
12.
Qiu, Lu, Lulu Liu, Lei Luo, et al.. (2021). Identification and Comprehensive Structural and Functional Analyses of the EXO70 Gene Family in Cotton. Genes. 12(10). 1594–1594. 3 indexed citations
13.
Zhao, Yumiao, Jiaxin Sun, Yin Li, et al.. (2021). Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3β/IL-8 signaling pathway. Acta Pharmaceutica Sinica B. 11(9). 2835–2849. 46 indexed citations
14.
Gou, Shanshan, Lu Qiu, Xiaowen Zhou, et al.. (2021). Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells. Toxicology and Applied Pharmacology. 420. 115523–115523. 16 indexed citations
15.
Chen, Jiayu, Meng Wang, Yuancai Xiang, et al.. (2020). Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/ β -Catenin-Dependent and Wnt/ β -Catenin-Independent Signaling Networks in the Human Liver Cancer. Oxidative Medicine and Cellular Longevity. 2020. 1–28. 15 indexed citations
16.
Ren, Yonggang, Yujiao Wang, Shuai Hao, et al.. (2020). NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway. Journal of Cancer. 11(23). 6939–6949. 38 indexed citations
17.
Xiang, Yuancai, Shaofan Hu, Meng Wang, et al.. (2018). Topovectorial mechanisms control the juxtamembrane proteolytic processing of Nrf1 to remove its N-terminal polypeptides during maturation of the CNC-bZIP factor. Toxicology and Applied Pharmacology. 360. 160–184. 16 indexed citations
18.
Ren, Yonggang, Lu Qiu, Feng-Lin Lu, et al.. (2016). TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Scientific Reports. 6(1). 23775–23775. 35 indexed citations
19.
Zhang, Yiguo, Shaojun Li, Yuancai Xiang, et al.. (2015). The selective post-translational processing of transcription factor Nrf1 yields distinct isoforms that dictate its ability to differentially regulate gene expression. Scientific Reports. 5(1). 12983–12983. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanliang Lin Breakdown of academic impact, for papers by Huifang Hu Breakdown of academic impact, for papers by Xiaofang Lu Breakdown of academic impact, for papers by Hai-Xia Qi Breakdown of academic impact, for papers by Xiuying Pei Breakdown of academic impact, for papers by Г. Е. Онищенко Breakdown of academic impact, for papers by Jiřina Procházková Breakdown of academic impact, for papers by Xinyuan Liu
Rankless by CCL
2026